8
ROS/NO/O2 1a. Introduction: Background

ROS/NO/O2 1a. Introduction: Background

  • Upload
    karik

  • View
    27

  • Download
    0

Embed Size (px)

DESCRIPTION

ROS/NO/O2 1a. Introduction: Background. ENDOTHELIAL FUNCTION OF SUBDERMAL MICROVESSELS, PLASMA ADMA AND ROS MARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 1 OR EARLY ESSENTIAL HYPERTENSION. Dan Wang, M.D., Ph.D. Christopher Wilcox, M.D., Ph.D. Sven Strangaard , Ph.D. - PowerPoint PPT Presentation

Citation preview

Page 1: ROS/NO/O2 1a. Introduction: Background

ROS/NO/O2

1a. Introduction: Background

Page 2: ROS/NO/O2 1a. Introduction: Background
Page 3: ROS/NO/O2 1a. Introduction: Background
Page 4: ROS/NO/O2 1a. Introduction: Background
Page 5: ROS/NO/O2 1a. Introduction: Background
Page 6: ROS/NO/O2 1a. Introduction: Background

• Dan Wang, M.D., Ph.D.• Christopher Wilcox, M.D., Ph.D.• Sven Strangaard, Ph.D.• Shakil Aslam, M.D.

ENDOTHELIAL FUNCTION OF SUBDERMAL MICROVESSELS, PLASMA ADMA AND ROS MARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 1 OR EARLY ESSENTIAL HYPERTENSION

Page 7: ROS/NO/O2 1a. Introduction: Background
Page 8: ROS/NO/O2 1a. Introduction: Background

CONCLUSIONS

• Humans with essential hypertension or CKD-1 have:– reduced

microvascular EDRF and NOS

– increased circulating ADMA

– oxidative stress